• linkedin
  • Increase Font
  • Sharebar

    Female urology research examines sling surgery, robotic approaches, mesh

    This article is part of the State of Urology 2014

    Shlomo Raz, MDDr. RazSling surgery, robotic approaches to sacrocolpopexy and pelvic organ prolapse, and mesh are among the key topics in the area of female urology to watch for at the 2014 AUA annual meeting.

    Specifically, here are the top abstract picks for female urology from this year's AUA annual meeting, as selected by Shlomo Raz, MD, professor of surgery/urology at UCLA:

    MP33-02: Prospective Multicenter Double-Blind Placebo-Controlled Trial of the Efficacy and Safety of Liposomal Botulinum Toxin-A Instillation vs. Placebo in Treatment of Patients with Refractory Overactive Bladder
    Yao-Chi Chuang

    MP33-03: The long-term outcomes from TVT procedure for female stress urinary incontinence; Data from minimal 13 years of follow-up
    Phil Hyun Song

    MP33-06: Long-Term Device Outcomes for Artificial Urinary Sphincter Reimplantation Following Prior Explantation for Erosion or Infection
    Brian Linder

    MP33-07: Success of Autologous Pubovaginal Sling Following Failed Midurethral Sling
    Jaclyn Milose

    MP33-11: The male transobturator sling has a high reoperation rate and increased cost in men with a history of radiation after prostatectomy: a cost-based analysis
    Shubham Gupta

    MP33-20: Anticholinergic Cycling and Treatment Outcomes in Overactive Bladder Patients with Urinary Incontinence
    Michael Chancellor

    MP38-13: Comparison of ROC Curves for Preoperative VLPP, MUCP and Urinary NTx As Predictors for Midurethral Sling Outcomes
    AeuMuro Lake

    Continue to next page for more abstracts.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available